Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 3Recurrence 2Myeloid Malignancies 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Blast Crisis 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5fludarabine 5Whole-Body Irradiation 4Busulfan 4Biopsy 4Specimen Handling 3Injections 3Cytarabine 3venetoclax 2decitabine and cedazuridine drug combination 2Tacrolimus 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Lenalidomide 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclosporine 2CPX-351 2Azacitidine 2treosulfan 1peginterferon alfa-2b 1olutasidenib 1itacitinib 1canakinumab 1aldesleukin 1X-Rays 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Chronic × Decitabine × 30 days × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡